SavedAdd your journal

Journals / European Journal of Therapeutics / 2020 / Cilt: 26 - Sayı: 4

The Predictive Role of Heat Shock Proteins 27 and 60in Pediatric Patients with Ataxia Telangiectasia

Peren PERK
Beltinge DEMİRCİOĞLU KILIÇ
A. Aysima ÖZÇELİK
Binnur ÖZYURT
Pages
287–290
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

HSP 27 and 60 levels were measured from serum samples of AT patients using an enzyme-linked immunosorbent assay and compared with those of healthy controls.Results: Serum levels of HSP 27 and 60 were higher in patients with AT than in age-matched healthy controls (p=0.010 and p=0.000, respectively).Conclusion: In AT patients, levels of HSP 27 and 60 are increased to prevent tissue injury; therefore, treatment targeting HSPs may prevent disease progression and development of secondary malignancy in this patient population.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aimed to measure the levels of heat shock proteins (HSP) 27 and 60 as mediators for hypoxia and tissue injury in pediatric patients with ataxia telangiectasia (AT).
📊
Key Findings & Data:Another aim was to determine the prognostic role of HSP 27 and 60 in AT.Methods: This study analyzed the data of AT patients (n=15) aged 4-16 years and of age-matched healthy controls (n=20).
💡
Conclusion & Impact:HSP 27 and 60 levels were measured from serum samples of AT patients using an enzyme-linked immunosorbent assay and compared with those of healthy controls.Results: Serum levels of HSP 27 and 60 were higher in patients with AT than in age-matched healthy controls (p=0.010 and p=0.000, respectively).Conclusion: In AT patients, levels of HSP 27 and 60 are increased to prevent tissue injury; therefore, treatment targeting HSPs may prevent disease progression and development of secondary malignancy in this patient population.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: This study aimed to measure the levels of heat shock proteins (HSP) 27 and 60 as mediators for hypoxia and tissue injury in pediatric patients with ataxia telangiectasia (AT). Another aim was to determine the prognostic role of HSP 27 and 60 in AT.Methods: This study analyzed the data of AT patients (n=15) aged 4-16 years and of age-matched healthy controls (n=20). HSP 27 and 60 levels were measured from serum samples of AT patients using an enzyme-linked immunosorbent assay and compared with those of healthy controls.Results: Serum levels of HSP 27 and 60 were higher in patients with AT than in age-matched healthy controls (p=0.010 and p=0.000, respectively).Conclusion: In AT patients, levels of HSP 27 and 60 are increased to prevent tissue injury; therefore, treatment targeting HSPs may prevent disease progression and development of secondary malignancy in this patient population.

🔖

Cite This Article

PERK, P., KILIÇ, B. D., ÖZÇELİK, A. A., ÖZYURT, B. (2022). The Predictive Role of Heat Shock Proteins 27 and 60in Pediatric Patients with Ataxia Telangiectasia. European Journal of Therapeutics, Cilt: 26 - Sayı: 4, 287–290. https://ajindex.com/articles/512188

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. McKinnon PJ. ATM and ataxia telangiectasia. EMBO Rep 2004
  2. [Crossref] 2. Chun HH, Gatti RA. Ataxia-telangiectasia, an evolving phenotype. DNA Repair (Amst) 2004
  3. [Crossref] 3. Humar B, Muller H, Scott RJ. Cell cycle dependent DNA break increase in ataxia telangiectasia lymphoblasts after radiation exposure. Mol Pathol 2001
  4. [Crossref] 4. Sharp FR, Massa SM, Swanson RA. Heat-shock protein protection. Trends Neurosci 1999
  5. [Crossref] 5. Perschinka H, Mayr M, Millonig G, Mayerl C, Van der Zee R, Morrison SG, et al. Cross-reactive B-cellepitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler Thromb Vasc Biol 2003
  6. [Crossref] 6. Magen D, Georgopoulos C, Bross P, Ang D, Segev Y, Goldsher D, et al. Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy. Am J Hum Genet 2008
  7. [Crossref] 7. Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 1997
  8. Multhoff G. Heat-shock protein 70 (HSP 70): membrane location, export and immunological relevance. Methods 2007
  9. [Crossref] 9. Bukau B, Horwich AL. The HSP 70 and HSP 60 chaperone machines. Cell 1998
  10. [Crossref] 10. Franklin TB, Krueger-Naug AM, Clarke DB, Arrigo AP, Currie RW. The role of heat shock proteins HSP 70 and HSP 27 in cellular protection of the central nervous system. Int J Hyperthermia 2005
  11. [Crossref] 11. Di Domenico F, Sultana R, Tiu GF, Scheff NN, Perluigi M, Cini C, et al.Protein levels of heat-shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer disease. Brain Res 2010
  12. [Crossref] 12. Raaphorst GP, Azzam EI. Hyperthermia enhances X ray cell killing in normal and homozygous and heterozygous ataxia telangiectasia human cells. Int J Radiat Oncol Biol Phys 1985
  13. [Crossref] 13. Akbar MT, Lundberg AM, Liu K, Vidyadaran S, Wells KE, Dolatshad H, et al. The neuroprotective effects of heat shock protein 27 overexpression in transgenic animals against kainate-induced seizures and hippocampal cell death. J Bi